Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCR-DReSS guided therapy in metastatic gastric cancer
NCT03170180Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Mar 2017
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib, gefitinib, imatinib in gastric cancer (GC), sponsored by Samsung Medical Center. Started Mar 2017; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03170180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170180.